PTX prescient therapeutics limited
Add to My Watchlist 8.70% ! 4.2¢

PTX has been pushing for this milestone for fast track approval...

  1. newregime
    2,111 Posts.
    lightbulb Created with Sketch. 823
    clock Created with Sketch.
    16/04/25
    09:41
    Post #: 78707712
    PTX has been pushing for this milestone for fast track approval for sometime.
    WELL DONE. Looking forward to this announcement being reflected in the share price and also the investor briefing at 12pm tomorrow by James.
    PTX Price at posting: 4.2¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 24  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Progress in Phelan-McDermid Syndrome Program to Be Presented at PMS Global Congress
right-arrow Created with Sketch.
NEWS Orthocell Announces First US Surgical Use of Remplir Following FDA Clearance
right-arrow Created with Sketch.
NEWS 30,000m Diamond Drilling Commences at Napie Gold Project
right-arrow Created with Sketch.
NEWS Strong Rock Chip Assays Include 18.4g/t Au from Waitekauri
right-arrow Created with Sketch.
NEWS High-Grade Scandium Assays Returned at Syerston from Drilling Campaign
right-arrow Created with Sketch.
CLA Celsius Resources Commences FEED and Feasibility Study at MCB Project Site
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
4.2¢ 		Change
-0.004(8.70%) 		Mkt cap ! $34.62M
Open High Low Value Volume
4.6¢ 4.6¢ 4.1¢ $137.6K 3.202M

Buyers (Bids)

No. Vol. Price($)
1 211 4.7¢
 

Sellers (Offers)

Price($) Vol. No.
4.3¢ 210 1
View Market Depth
Last trade - 15.56pm 30/06/2025 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.